D-0386-2021 Class III Terminated

Recalled by KVK-Tech, Inc. — Newtown, PA

FDA drug recall D-0386-2021 was initiated by KVK-Tech, Inc. on Apr 27, 2021 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Oct 5, 2022). Affected quantity: 17,096 bottles.

Recall details

Product Type
Drugs
Report Date
May 26, 2021
Initiation Date
Apr 27, 2021
Termination Date
Oct 5, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,096 bottles

Product description

Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-Tech, Inc., Newtown, PA, 18940 NDC 10702-055-03

Reason for recall

Failed Impurities/Degradation Specifications

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot: 15684A, Exp 7/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0386-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0386-2021. Report a data issue: hello@regdatalab.com.